Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rajendra Kumar Pahan"'
Autor:
Manish Gutch, Abhay Joshi, Sukriti Kumar, Avinash Agarwal, Rajendra Kumar Pahan, Syed Mohd Razi
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 6, Pp 898-902 (2017)
The dipeptidyl peptidase-4 (DPP-4) inhibitors have facilitated the management of type 2 diabetes mellitus (T2DM) owing to their superior efficacy and safety with low incidence of adverse effects. Gemigliptin is a new member of this family of drugs, a
Externí odkaz:
https://doaj.org/article/69f76787a15e466495275bb5ff2fe76b
Publikováno v:
CHRISMED Journal of Health and Research, Vol 4, Iss 3, Pp 198-200 (2017)
Insulin autoimmune syndrome is defined as the occurrence of spontaneous hypoglycemia attacks with high titers of anti-insulin autoantibodies in patients with no previous exposure to insulin. This rare syndrome has mostly been reported from the Japane
Externí odkaz:
https://doaj.org/article/fc09cfb9a36f432c930a69ea837e2bfb
Autor:
Manish Gutch, Annesh Bhattacharya, Sukriti Kumar, Syed Mohd Razi, Rao Somendra Singh, Rajendra Kumar Pahan
Publikováno v:
CHRISMED Journal of Health and Research, Vol 4, Iss 2, Pp 144-146 (2017)
Resistance to thyroid hormone (RTH) syndrome is a very rare disorder characterized by mutations of the thyroid hormone receptor beta and is usually inherited as an autosomal dominant trait. Patients with RTH are usually euthyroid but rarely may prese
Externí odkaz:
https://doaj.org/article/20fe25a1f96b4d6a9946049c89c46ab5
Publikováno v:
International Journal of Medicine and Public Health. 8:45-47
Autor:
Avinash Agarwal, Sukriti Kumar, Rajendra Kumar Pahan, Syed Mohd Razi, Manish Gutch, Abhay Joshi
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 6, Pp 898-902 (2017)
Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 6, Pp 898-902 (2017)
The dipeptidyl peptidase-4 (DPP-4) inhibitors have facilitated the management of type 2 diabetes mellitus (T2DM) owing to their superior efficacy and safety with low incidence of adverse effects. Gemigliptin is a new member of this family of drugs, a
Publikováno v:
International Journal of Medicine and Public Health. 7:127-129
Autor:
Rao Somendra Singh, Syed Mohd Razi, Manish Gutch, Annesh Bhattacharya, Sukriti Kumar, Rajendra Kumar Pahan
Publikováno v:
CHRISMED Journal of Health and Research, Vol 4, Iss 2, Pp 144-146 (2017)
Resistance to thyroid hormone (RTH) syndrome is a very rare disorder characterized by mutations of the thyroid hormone receptor beta and is usually inherited as an autosomal dominant trait. Patients with RTH are usually euthyroid but rarely may prese
Publikováno v:
CHRISMED Journal of Health and Research, Vol 4, Iss 3, Pp 198-200 (2017)
Insulin autoimmune syndrome is defined as the occurrence of spontaneous hypoglycemia attacks with high titers of anti-insulin autoantibodies in patients with no previous exposure to insulin. This rare syndrome has mostly been reported from the Japane